Headquarters
510 CHARMANY DR STE 270, MADISON, WI 53719-1267, US
MADISON, WI, US
ADVANTIGEN BIOSCIENCES LLC
From the company
AdvantiGen Biosciences is expanding the landscape of Immuno-Oncology by unveiling sialic-acid-binding immunoglobulin-like lectin 5 (Siglec-5) as a novel target on activated T-cells for cancer immunotherapy. The company capitalizes on its expertise in monoclonal antibodies (mAbs) and NIRID (Near InfraRed Identification and Detection) to develop therapeutics and complementary biomarkers for pre-clinical and clinical patient selection and stratification.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.